When was Sime Dx founded?

Sime Dx was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is Sime Dx located?

Sime Dx is headquartered in London, United Kingdom. It is registered at SIME DIAGNOSTICS LTD.

Who is the current CEO of Sime Dx?

Povl Verder of Sime Dx. They have also founded 1 company.

Which legal entities is Sime Dx associated with?

Sime Dx is associated with Sime Diagnostics Ltd.

How many employees does Sime Dx have?

As of Mar 31, 2026, the latest employee count at Sime Dx is 32.

Is Sime Dx a funded company?

Sime Dx is a funded company, having raised a total of $971K across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 09, 2014.

When was the latest funding round of Sime Dx?

Sime Dx's latest funding was a $***** Seed round on May 12, 2020, with participation from 0 investor.

Where does Sime Dx rank among its competitors?

Sime Dx ranks 44th amongst 344 active competitors, of which 93 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Scopio Labs, which secured $10M in Jul, 2025.

Who are the top competitors of Sime Dx?

Sime Dx's top competitors include PathAI, PAIGE and Pictor Labs. Among them, Scopio Labs secured the most recent funding round in July, 2025.

Sime Dx - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Website: simedx.com
Registered Address: SIME DIAGNOSTICS LTD

Key Metrics

Founded Year

2010

Location

London, United Kingdom

Stage

Seed

Total Funding

$971K in 5 rounds

Latest Funding Round

Seed, May 12, 2020, $*****

Investors

Oxford Technology & 13 more

Ranked

44^th among 344 active competitors

Employee Count

32 as on Mar 31, 2026

Similar Companies

PathAI & 327 more

View Sime Dx's full profile

Sime Dx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sime Diagnostics Ltd CIN: 08881197 , United Kingdom, Active	Feb 06, 2014	-	7 (As on Mar 31, 2021)

Sime Dx has raised a total funding of $971K over 5 rounds. Its first funding round was on Apr 09, 2014. Sime Dx has 7 institutional investors and 7 angel investors.

Here is the list of recent funding rounds of Sime Dx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 12, 2020	1478887	Seed	9988328	8859833	5584887	5923971
Feb 26, 2019	5542680	Seed	7763098	8526958	6299953	Oxford Technology
Apr 07, 2016	1276562	Seed	8103954	3263957	3053690	Oxford Technology

Access funding benchmarks and valuations. Sign up today!

View details of Sime Dx's funding rounds and investors

The founders of Sime Dx are Povl Verder, Omer Casher and Morgaine Matthews. Povl Verder is the CEO of Sime Dx.

Here are the details of Sime Dx's key team members:

Povl Verder: Founder & CEO of Sime Dx.
Omer Casher: Co-Founder & COO of Sime Dx.
Morgaine Matthews: Co-Founder of Sime Dx.

View details of Sime Dx's Founder profiles and Board Members

Sime Dx's employee count trend

Sime Dx has 32 employees as of Mar 26. Here is Sime Dx's employee count trend over the years:

Uncover Sime Dx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sime Dx include PathAI, PAIGE and Pictor Labs. Here is the list of Top 10 competitors of Sime Dx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Polaris Partners & 21 others	70/100
2nd	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	66/100
3rd	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, LabCorp & 4 others	64/100
4th	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
5th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	62/100
6th	EnSpectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Heuristic Capital Partners ... & 5 others	62/100
7th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
8th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, Scale Venture Partners ... & 22 others	59/100
9th	Scopio Labs 2014, Tel Aviv (Israel), Series D	Developer of digital imaging platforms for hematology	$125M	OurCrowd, OTV & 15 others	58/100
10th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$35.4M	ARUP Laboratories, Zoetis & 1 others	58/100
44th	Sime Dx 2010, London (United Kingdom), Seed	Point-of-care digital digital diagnostics	$971K	Oxford Technology, Microsoft Accelerator ... & 12 others	44/100